“Evaluation of Risk Markers Fluctuation During an Initial Therapy With Rosiglitazon in Patients Suffering from Metabolic Syndrome”. 2009. Biomolecules and Biomedicine 9 (4): 320-28. https://doi.org/10.17305/bjbms.2009.2788.